Study highlights the negative impacts of low food diversity on child health and economic costs, emphasizing the need for improved dietary variety to reduce healthcare expenses.
Septerna raises $150m in Series B funding round
A PTH1R agonist programme of Septerna is being developed to treat hypoparathyroidism. Credit: Kateryna Kon via Shutterstock.com. Biotechnology firm Septerna has raised $150m in a Series B funding round
July 12, 2023